Published in Clin Transplant on January 11, 2010
Resection of pulmonary metastases from hepatocellular carcinoma following liver transplantation. World J Surg (2012) 0.87
Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation. Clin Mol Hepatol (2014) 0.80
Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2014) 0.77
Clinical mycophenolic acid monitoring in liver transplant recipients. World J Gastroenterol (2014) 0.76
Negative pressure wound therapy for inguinal lymphatic complications in critically ill patients. J Korean Surg Soc (2013) 0.75
Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy. Ann Hepatobiliary Pancreat Surg (2017) 0.75
Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology (2006) 3.02
Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl (2006) 2.58
Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl (2008) 2.22
Living donor liver transplantation: the Asian perspective. Transplantation (2014) 2.13
Ligation of left renal vein for large spontaneous splenorenal shunt to prevent portal flow steal in adult living donor liver transplantation. Transpl Int (2007) 2.10
Reappraisal of percutaneous transhepatic biliary drainage tract recurrence after resection of perihilar bile duct cancer. World J Surg (2012) 1.73
Restoration of portal flow using a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric thrombosis. Liver Transpl (2014) 1.66
Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol (2010) 1.61
Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl (2007) 1.59
Donor selection for procurement of right posterior segment graft in living donor liver transplantation. Liver Transpl (2004) 1.56
Characteristics and management of splenic artery aneurysms in adult living donor liver transplant recipients. Liver Transpl (2009) 1.52
Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50
Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients. Liver Transpl (2010) 1.46
Improved outcomes in liver transplantation in children with acute liver failure. J Pediatr Gastroenterol Nutr (2014) 1.45
Clinical value of APACHE scores in patients who require intensive care before liver transplantation. Hepatogastroenterology (2009) 1.45
The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl (2004) 1.41
[Clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis]. Korean J Hepatol (2007) 1.38